Obesity drug semaglutide fails to slow Alzheimer’s BBCSemaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says CNNNovo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target CNBCNovo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials The GuardianWeight-loss drugs: What other conditions are they being used and tested for? Reuters
